Japanese Assessment of BMIPP and CTA for Diagnostic utility in Suspected Angina Patients

Japanese Assessment of BMIPP and CTA for Diagnostic utility in Suspected Angina Patients - Japanese Assessment of BMIPP and CTA for Diagnostic utility in Suspected Angina Patients (J-ABCD Study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007606

Enrollment

150

Registered

2012-03-31

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Suspected ischemic heart disease patients due to who has chest pain and/or exertional breathlessness 2)Patients(age above 20) who are obtained written informed consent

Exclusion criteria

Exclusion criteria: 1)History of myocardial infarction 2)Acute coronary syndrome 3)History of hospitalization by heart failuer 4)History of coronary revascularization 5)CKD patient(eGFR<=50mL/min/1.73m2) 6)Uncontrollable arrhythmia or AF 7)Uncontrollable hypertension 8)Overt valve regurgitation and/or moderate to severe valvular disease on UCG 9)Coronary angiography or CT angiography within 2 months before registration 10)Drug hypersensitivity with BMIPP and Tetrofosmin 11)Unsuitable for registration by investigator

Design outcomes

Primary

Measure	Time frame
Cardiac death, Sudden death	—

Secondary

Measure	Time frame
Non fatal myocardial infarction, hospitalization for heart failure or unstable angina, stroke, aorta dissection, aorta rupture, pulmonary embolism, performed PCI or CABG	—

Countries

Japan

Contacts

Public ContactTakehana Kazuya

Kansai Medical University Second Department of Medicine

takehana@hirakata.kmu.ac.jp06-6992-1001

Outcome results